News

1 to 9 of 11 results

Urgent action needed to address Clostridium difficile infections in Europe

Urgent action needed to address Clostridium difficile infections in Europe

03-12-2014

Urgent action is needed to address the current issues relating to the management of health care-acquired…

Antibiotics and Infectious diseasesEuropeEuropean ParliamentPharmaceuticalPolitics

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

UK Ministers “must stop unnecessary use of antibiotics”

UK Ministers “must stop unnecessary use of antibiotics”

07-07-2014

A wide-raging report published today by the UK House of Commons Science and Technology Select Committee…

Antibiotics and Infectious diseasesHealthcarePharmaceuticalPoliticsResearchUK

TAC puts pressure on Janssen finalize development of TB drug bedaquiline

21-11-2013

The current standard of care for multi-drug resistant tuberculosis (MDR-TB) consists of poorly tested…

Antibiotics and Infectious diseasesbedaquilineJanssenJohnson & JohnsonPharmaceuticalPoliticsResearchRest of the World

India must address worrying stock out of tuberculosis drugs, says MSF

24-06-2013

The Indian government must urgently address the persistent issues and almost routine delays of procuring…

Antibiotics and Infectious diseasesAsia-PacificHealthcareMarkets & MarketingPharmaceuticalPolitics

EFPIA supports a new R&D model to tackle antimicrobial resistance

27-10-2011

A vote of the European Parliament’s Health Committee on the threat posed by antimicrobial resistance,…

Antibiotics and Infectious diseasesEuropePharmaceuticalPoliticsResearch

Venezuela invalidates two Bayer moxifloxacin patents

30-11-2009

Venezuela’s Minister of Trade, Eduardo Saman, announced that the Latin American country’s government…

Antibiotics and Infectious diseasesAspirinAveloxBayerBayerGenericsMoxifloxacinMoxifloxacin HCLPatentsPharmaceuticalPoliticsSouth AmericaVigamox

Malaria drug costs to be cut by Tanzania’s govt

25-11-2009

The cost of first line malaria drug in Tanzania, Allu, will be lowered to 400 shillings ($0.30) per dose,…

Anti-viralsAntibiotics and Infectious diseasesGeneralPharmaceuticalPoliticsPricingRest of the World

1 to 9 of 11 results

COMPANY SPOTLIGHT

Menarini

Back to top